HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Floyd, R. L. Articles by Cordero, J. F. Search for Related Content PubMed PubMed Citation Articles by Floyd, R. L. Articles by Cordero, J. F.

Recognition and Prevention of Fetal Alcohol Syndrome

From the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia; Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California; and Department of Obstetrics and Gynecology, Wayne State University, School of Medicine, Detroit, Michigan.

Alcohol use among women of childbearing age is prevalent in the United States, with approximately 1 in 5 nonpregnant women reporting binge drinking (5 or more drinks on any one occasion) and 1 in 25 pregnant women reporting binge drinking. Alcohol use during pregnancy results in a spectrum of adverse outcomes known as fetal alcohol spectrum disorders. Fetal alcohol syndrome (FAS) is one of these disorders. Fetal alcohol syndrome is characterized by specific facial abnormalities and significant impairments in neurodevelopment and physical growth. Early identification of children with FAS has been shown to enhance their long-term outcomes. In an effort to improve clinical recognition of children with this condition, Centers for Disease Control and Prevention (CDC) was directed by Congress in 2002 to lead the development of uniform diagnostic criteria for FAS and other prenatal alcohol-related conditions. The purpose of this commentary is to provide clinicians a summary of the report released by CDC describing the current diagnostic criteria for FAS. In addition, advancements have been made in screening and brief interventions for alcohol use disorders in women who have the potential to make significant strides in the prevention of FAS spectrum disorders. Knowledge of the diagnostic criteria for FAS can lead to increased identification of the syndrome in infants and children and the provision of appropriate medical and support services. Screening for and intervening with women at risk for an alcohol-exposed pregnancy can prevent FAS and other fetal alcohol spectrum disorders.

This article has been cited by other articles:

				J. R. Araujo, P. Goncalves, and F. Martel Modulation of Glucose Uptake in a Human Choriocarcinoma Cell Line (BeWo) by Dietary Bioactive Compounds and Drugs of Abuse J. Biochem., August 1, 2008; 144(2): 177 - 186. [Abstract] [Full Text] [PDF]

				D. Glik, M. Prelip, A. Myerson, and K. Eilers Fetal Alcohol Syndrome Prevention Using Community-Based Narrowcasting Campaigns Health Promot Pract, January 1, 2008; 9(1): 93 - 103. [Abstract] [PDF]

				D. Hall and J. Williams Safeguarding, child protection and mental health Arch. Dis. Child., January 1, 2008; 93(1): 11 - 13. [Abstract] [Full Text] [PDF]

				T. Cargiulo Understanding the health impact of alcohol dependence Am. J. Health Syst. Pharm., March 1, 2007; 64(5_Supplement_3): S5 - S11. [Abstract] [Full Text] [PDF]